Prior to joining the firm in November 2023, Daphna Fischel obtained a MSc in Neurobiology and Neurosciences from Tel Aviv University, with a research focus on Parkinson's Disease. Prior to that she worked for two years in New York as a research assistant at Foresite Capital, a healthcare focused private equity firm, and during college interned at Foresite Capital, Kite Pharma, the Cognitive Neuroscience Research Lab at Tel Aviv University, and DAFNA Capital. She received a BA in Neurosciences and a BS in Business Administration from the University of Southern California in Los Angeles.